Page last updated: 2024-08-24

nelfinavir and Carcinoma, Medullary

nelfinavir has been researched along with Carcinoma, Medullary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boyle, L; Burman, K; Costello, J; Jensen, K; Klubo-Gwiezdzinska, J; Kushchayeva, Y; Patel, A; Recupero, A; Vasko, V	1

Other Studies

1 other study(ies) available for nelfinavir and Carcinoma, Medullary

Article	Year
The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:5 Topics: Adult; Aged; Apoptosis; Autophagy; Carcinoma, Medullary; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Endoplasmic Reticulum Stress; Female; HIV Protease Inhibitors; HSP90 Heat-Shock Proteins; Humans; Male; Middle Aged; Mutation; Nelfinavir; Oxidative Stress; Proto-Oncogene Proteins c-ret; Signal Transduction; Thyroid Neoplasms	2014

Article

Year

The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.

The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:5

Topics: Adult; Aged; Apoptosis; Autophagy; Carcinoma, Medullary; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Endoplasmic Reticulum Stress; Female; HIV Protease Inhibitors; HSP90 Heat-Shock Proteins; Humans; Male; Middle Aged; Mutation; Nelfinavir; Oxidative Stress; Proto-Oncogene Proteins c-ret; Signal Transduction; Thyroid Neoplasms

2014